State Street Corp lifted its position in shares of Balchem Corporation (NASDAQ:BCPC) by 5.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 780,131 shares of the basic materials company’s stock after purchasing an additional 38,522 shares during the quarter. State Street Corp owned 2.44% of Balchem Corporation worth $60,619,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Capital Analysts LLC acquired a new stake in shares of Balchem Corporation during the 2nd quarter worth approximately $197,000. Schroder Investment Management Group grew its stake in shares of Balchem Corporation by 2.7% during the 2nd quarter. Schroder Investment Management Group now owns 88,691 shares of the basic materials company’s stock worth $6,871,000 after purchasing an additional 2,298 shares during the period. Macquarie Group Ltd. grew its stake in shares of Balchem Corporation by 47.1% during the 2nd quarter. Macquarie Group Ltd. now owns 351,899 shares of the basic materials company’s stock worth $27,346,000 after purchasing an additional 112,703 shares during the period. California Public Employees Retirement System grew its stake in shares of Balchem Corporation by 4.1% during the 2nd quarter. California Public Employees Retirement System now owns 74,300 shares of the basic materials company’s stock worth $5,774,000 after purchasing an additional 2,900 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of Balchem Corporation by 1.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 723,504 shares of the basic materials company’s stock worth $56,223,000 after purchasing an additional 8,869 shares during the period. 84.86% of the stock is currently owned by institutional investors and hedge funds.
Shares of Balchem Corporation (NASDAQ:BCPC) opened at 84.29 on Wednesday. The firm has a market cap of $2.69 billion, a PE ratio of 43.67 and a beta of 1.12. The company has a 50-day moving average of $81.23 and a 200-day moving average of $78.96. Balchem Corporation has a 1-year low of $67.71 and a 1-year high of $89.50.
Balchem Corporation (NASDAQ:BCPC) last released its quarterly earnings results on Friday, August 4th. The basic materials company reported $0.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.01. Balchem Corporation had a return on equity of 14.99% and a net margin of 10.99%. The business had revenue of $147.08 million during the quarter. Analysts predict that Balchem Corporation will post $2.47 earnings per share for the current fiscal year.
Separately, BidaskClub cut shares of Balchem Corporation from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st.
Balchem Corporation Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Corporation (NASDAQ:BCPC).
What are top analysts saying about Balchem Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Balchem Corporation and related companies.